Arterial hypertension and Type 2 diabetes mellitus: any benefits for angiotensin II receptor blockers?

by V. V. Fomin, S. V. Moiseev, E. A. Saginova
Published 2007-06-01

CLINICOPATHOGENETIC CHARACTERISTICS OF CARDIORENAL SYNDROME IN NON-ALCOHOLIC FATTY DISEASE OF THE LIVER

by M M Severova, E A Saginova, M G Gallyamov, N V Ermakov, A V Rodina, V V Fomin, N A Mukhin
Published 2012-06-01

Significance of the factors of hypoxia and endothelial dysfunction in kidney injury in the presence of obesity

by M G Galliamov, E A Saginova, M M Severova, L M Samokhodskaia, T N Krasnova, V I Sholomova, Iu D Sorokin, N A Mukhin
Published 2013-06-01

Association of obstructive sleep apnea syndrome with the signs of non-alcoholic fatty liver disease and calculated glomerular filtration rate in metabolic syndrome

by M M Severova, V V Fomin, M V Lebedeva, Yu D Sorokin, E A Saginova, E G Minakova, M G Gallyamov, N A Mukhin
Published 2010-06-01

REMODELING OF CARDIOVASCULAR SYSTEM AND DEVELOPMENT OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH METABOLIC SYNDROME AND OBESITY: ROLE OF GENES ENOS, SUBUNIT P22-PHOX OF NADPH-OXIDASE...

by E A Saginova, M G Gallyamov, A V Balatsky, A V Kolotvin, M V Severova, L M Samokhodskaya, V V Fomin, T N Krasnova, N A Mukhin
Published 2012-06-01

The role of leptin, adiponectin and insulin-resistance markers in development of early stages of chronic kidney disease and atherosclerosis of carotid arteries in obese patients

by Evgeniya Andreevna Saginova, Marat Gaptelkhakovich Gallyamov, Mariya Mikhaylovna Severova, Ol'ga Aleksandrovna Surkova, Viktor Viktorovich Fomin, Nikolay Valentinovich Ermakov, Alla Valer'evna Rodina, Nikolay Alekseevich Mukhin, E A Saginova, M G Gallyamov, M M Severova, O A Surkova, V V Fomin, N V Ermakov, A V Rodina, N A Mukhin
Published 2011-06-01